|
FY2025
12 months to Dec 31, 2025
|
|
|---|---|
| CASH FLOWS FROM OPERATING ACTIVITIES: | |
| Net loss | |
| Adjustments to reconcile net loss to net cash used in operating activities: | |
| Depreciation and amortization | |
| Stock based compensation | |
| Amortization of license fees | |
| Amortization of right-of-use assets, net of liabilities | |
| Amortization of debt discount | |
| Change in fair value of derivative liability | |
| Loss on issuance of convertible note | |
| Changes in operating assets and liabilities: | |
| Accounts receivable | |
| Inventory | |
| Prepaid expenses and other assets | |
| Accounts payable | |
| Accrued liabilities | |
| Interest payable | |
| Deferred revenue | |
| Net cash used in operating activities | |
| CASH FLOWS FROM FINANCING ACTIVITIES: | |
| Proceeds from issuance of convertible notes payable | |
| Proceeds from issuance of Series D preferred stock | |
| Proceeds from issuance of pre-delivery shares | |
| Deferred offering costs | |
| Net cash provided by financing activities | |
| Decrease in cash and cash equivalents | |
| Cash and cash equivalents, beginning of year | |
| Cash and cash equivalents, end of year | |
| Non-cash disclosures of cash flow information: | |
| Deferred offering costs – issuance of common stock issued as offering costs | |
| Derivative liabilities recognized as debt discounts |
Loading...
